June is Cancer #ImmunotherapyMonth . Thanks to dramatic advances in the field, the ability to create new therapies that benefit more patients is here right now. In January, I shared my perspective on the future of immunotherapy with the #AACRBlog :
bit.ly/3qzOn97
#CIM23

At #AACR24 , new clinical data demonstrated the promise of therapeutic vaccines for aggressive cancers, including pancreatic and head and neck cancers. Learn more on the #AACRBlog : bit.ly/3TYME8k

To raise awareness about the higher incidence of prostate cancer in Black men, researchers presented a video at #AACR24 pairing a Black pastor with a urologist that led to 93% of viewers saying they would get screened: Read more on the #AACRBlog : bit.ly/3TYewt2.

Therapeutic vaccines showed promise against aggressive cancers in clinical trials presented at #AACR24 . Learn more on the #AACRBlog : bit.ly/3UfqqAa #AACR24

Register to attend the inaugural Blood Cancer Discovery Symposium. The Chairs and Editors-in-Chief Kenneth C. Anderson and Riccardo Dalla-Favera discuss this exciting initiative in a recent interview:
bit.ly/49DnF0h
AACR #AACRBlog

The first quarter of 2024 brought 14 new U.S. FDA approvals for cancer, including a new type of cell-based immunotherapy for melanoma. Learn more on the #AACRBlog : bit.ly/4cXIV3A

In a poster at #AACR24 , Eddie Cliff revealed that of the 129 cancer drug-indication pairs approved under FDA’s accelerated approval pathway between 2013-2023, only 43% demonstrated a clinical benefit in confirmatory trials. Read more on the #AACRBlog : bit.ly/3vLo9TX

In 2024, I’d like more scientists to recognize that they don’t have to carry the weight of addressing disparities alone. Let’s acknowledge that we need a team.

#AACRBlog #Cancer #healthequity

Register by February 2 for discounted rates to attend the inaugural Blood Cancer Discovery Symposium. The Chairs and Editors-in-Chief Kenneth C. Anderson and Riccardo Dalla-Favera discuss this exciting initiative in a recent interview:
bit.ly/42uUL0l
AACR #AACRBlog

Well,, this made me smile.
Such hope-filled, determined statements from leading KRAS researchers

David Tuvenson, Mariano Barbacid, Dafna Bar-Sagi, Frank McCormick Kevan Shokat Andrew Aguirre

Thanks AACR

#AACRBlog KRASKickers #AACR23
vimeo.com/817973736

Here is our latest AACR Annual Forecast #AACRBlog on cancer health equity. Thanks to Dr. Rob Winn, a leading expert on this important topic.

Here are the 2024 Global Scholar-in-Training Awardees (GSITAs) who will be attending the AACR Annual Meeting in San Diego, CA. You can learn more about this program by reading the inspiring insights from our 2023 GSITA alumni below #AACR blog #AACR GlobalScholars #AACR 24 #AACR

'Historically, whenever there’s a new innovation, it does not lead to impact for all people equally,” says CRCHD grantee Dr. Rob Winn. “If we’re not cognizant of that, we will continue to create the same inadvertent disparities.” Visit the #AACRBlog to learn more from Dr. Winn. ⤵️